BRAINSPAR-eDT unveils a novel anti-obesity compound, PEGyAMPH.

- 🧪 Reduces weight gain without affecting food intake.
- ⚙️ Enhances lipolysis and thermogenesis.
- 🫀 No cardiovascular side effects noted.
- 📈 Improves insulin sensitivity, distinct from AMPH.

#CellMetab #ObesityResearch #BRAINSPAR https://tnyp.me/kzRoO838/m